Prevention of insulin-dependent diabetes: where are we now?
Pozzilli
P
P
Clinica Medica II, University of Rome La Sapienza, Italy.
D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control*; D005387:Finland; D006801:Humans; D007165:Immunosuppression Therapy; D007328:Insulin / Q000627:therapeutic use; D051379:Mice; D009520:New Zealand; D009536:Niacinamide / Q000627:therapeutic use; D011322:Primary Prevention
D000941:Antigens; D007328:Insulin; D009536:Niacinamide